| The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic … MS Albert, ST DeKosky, D Dickson, B Dubois, HH Feldman, NC Fox, ... Alzheimer's & dementia 7 (3), 270-279, 2011 | 12003 | 2011 |
| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ... Neurology 65 (12), 1863-1872, 2005 | 9204* | 2005 |
| Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis M Neumann, DM Sampathu, LK Kwong, AC Truax, MC Micsenyi, TT Chou, ... Science 314 (5796), 130-133, 2006 | 7320 | 2006 |
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria B Dubois, HH Feldman, C Jacova, ST DeKosky, P Barberger-Gateau, ... The Lancet Neurology 6 (8), 734-746, 2007 | 5745 | 2007 |
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS M DeJesus-Hernandez, IR Mackenzie, BF Boeve, AL Boxer, M Baker, ... Neuron 72 (2), 245-256, 2011 | 5657 | 2011 |
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 3866 | 2014 |
| Mild cognitive impairment S Gauthier, B Reisberg, M Zaudig, RC Petersen, K Ritchie, K Broich, ... The lancet 367 (9518), 1262-1270, 2006 | 3781 | 2006 |
| Revising the definition of Alzheimer's disease: a new lexicon B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ... The Lancet Neurology 9 (11), 1118-1127, 2010 | 2503 | 2010 |
| Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 M Baker, IR Mackenzie, SM Pickering-Brown, J Gass, R Rademakers, ... Nature 442 (7105), 916-919, 2006 | 2315 | 2006 |
| Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 2025 | 2016 |
| Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1929 | 2016 |
| A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers CR Jack Jr, DA Bennett, K Blennow, MC Carrillo, HH Feldman, GB Frisoni, ... Neurology 87 (5), 539-547, 2016 | 1808 | 2016 |
| Nonpharmacological therapies in Alzheimer’s disease: a systematic review of efficacy J Olazarán, B Reisberg, L Clare, I Cruz, J Peña-Casanova, T Del Ser, ... Dementia and geriatric cognitive disorders 30 (2), 161-178, 2010 | 1352 | 2010 |
| Dementia with Lewy bodies I McKeith, J Mintzer, D Aarsland, D Burn, H Chiu, J Cohen-Mansfield, ... The Lancet Neurology 3 (1), 19-28, 2004 | 1155 | 2004 |
| Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 11934, 2016 | 1120 | 2016 |
| Treatment of Alzheimer's disease; current status and new perspectives P Schelterns, H Feldman The Lancet Neurology 2 (9), 539-547, 2003 | 979 | 2003 |
| A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease H Feldman, S Gauthier, J Hecker, B Vellas, P Subbiah, E Whalen, ... Neurology 57 (4), 613-620, 2001 | 938 | 2001 |
| Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group B Dubois, N Villain, GB Frisoni, GD Rabinovici, M Sabbagh, S Cappa, ... The Lancet Neurology 20 (6), 484-496, 2021 | 859 | 2021 |
| Clinical trials and late‐stage drug development for A lzheimer's disease: an appraisal from 1984 to 2014 LS Schneider, F Mangialasche, N Andreasen, H Feldman, E Giacobini, ... Journal of internal medicine 275 (3), 251-283, 2014 | 813 | 2014 |
| Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup RA Sperling, CR Jack Jr, SE Black, MP Frosch, SM Greenberg, BT Hyman, ... Alzheimer's & Dementia 7 (4), 367-385, 2011 | 801 | 2011 |